Sun Pharma's two US arms to pay $85 million in settlement pacts over antritrust litigation
The subsidiaries will make an aggregate payment amounting to a combined total of $85 million in exchange for a full release of all claims asserted against them in the direct purchaser action by the settlement class members.
United States Sun Pharma Taro Pharmaceuticals United Statesa Inc Generic Pharmaceuticals Pricing Antitrust Litigation Sun Pharmaceutical Industries Ltd Sun Pharmaceutical Industries On
Source: businesstoday.in